J Korean Med Sci.  2015 Oct;30(10):1476-1482. 10.3346/jkms.2015.30.10.1476.

Neonatal Morbidities Associated with Histologic Chorioamnionitis Defined Based on the Site and Extent of Inflammation in Very Low Birth Weight Infants

Affiliations
  • 1Department of Pediatrics, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea.
  • 2Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea. choicw@snu.ac.kr
  • 3Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
  • 4Department of Pediatrics, Asan Medical Center Children's Hospital, Seoul, Korea.
  • 5Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

Conflicting results on the influences of histologic chorioamnionitis (HC) on neonatal morbidities might be partly originated from using different definition of HC. The aim of this study was to determine the relationship between HC and neonatal morbidities using definition of HC that reflects the site and extent of inflammation. This was a retrospective cohort study of 261 very low birth weight (VLBW) infants admitted at a tertiary academic center. Based on the site of inflammation, HC was categorized: any HC; amnionitis; funisitis; amnionitis+funisitis. The extent of inflammation in each site was reflected by sub-defining high grade (HG). The incidences of morbidities in infants with and without HC were compared. The bronchopulmonary dysplasia (BPD) rate was significantly higher in infants with amnionitis and the severe retinopathy of prematurity (ROP) rate was significantly higher in infants with any HC and funisitis. After adjustment for both gestational age and birth weight, the respiratory distress syndrome (RDS) rate was significantly lower in infants with all categories of HC except for HG amnionitis and HG funisitis, which are not associated with lower RDS rate. HG amnionitis was significantly associated with increased BPD rate but the association of HC with severe ROP disappeared. In conclusion, HC is significantly associated with decreased RDS and HG amnionitis with increased BPD while lacking association with other neonatal morbidities in VLBW infants. The association with HC and neonatal morbidities differs by the site and extent of chorioamnionitis.

Keyword

Chorioamnionitis; Amnionitis; Morbidity; Infant, Very Low Birth Weight; Infant, Premature

MeSH Terms

Adult
Birth Weight
Bronchopulmonary Dysplasia/complications/*epidemiology
Chorioamnionitis/classification/*epidemiology/pathology
Cohort Studies
Female
Gestational Age
Humans
Infant, Newborn
*Infant, Very Low Birth Weight
Neutrophil Infiltration/immunology
Placenta/pathology
Pre-Eclampsia/*epidemiology/pathology
Pregnancy
Respiratory Distress Syndrome, Newborn/complications/*epidemiology
Retinopathy of Prematurity/complications/*epidemiology
Retrospective Studies
Tertiary Care Centers

Cited by  1 articles

The Influence of Pregnancy Disorders Causing Preterm Delivery on In-Hospital Outcomes in Preterm Infants at Less than 32 Weeks of Gestation
Jeong Min Shin, Jin A Lee, Hye Ri Yun, Sohee Oh, Jin A Sohn, Seung Han Shin, Chang Won Choi, Ee-Kyung Kim, Han-Suk Kim, Byeong-Il Kim
Perinatology. 2017;28(4):119-126.    doi: 10.14734/PN.2017.28.4.119.


Reference

1. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000; 183:1124–1129.
2. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005; 192:1162–1166.
3. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005; 22:155–159.
4. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006; 195:803–808.
5. Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology. 2011; 99:316–319.
6. Erdemir G, Kultursay N, Calkavur S, Zekioğlu O, Koroglu OA, Cakmak B, Yalaz M, Akisu M, Sagol S. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol. 2013; 54:267–274.
7. Soraisham AS, Trevenen C, Wood S, Singhal N, Sauve R. Histological chorioamnionitis and neurodevelopmental outcome in preterm infants. J Perinatol. 2013; 33:70–75.
8. Lee HJ, Kim EK, Kim HS, Choi CW, Kim BI, Choi JH. Chorioamnionitis, respiratory distress syndrome and bronchopulmonary dysplasia in extremely low birth weight infants. J Perinatol. 2011; 31:166–170.
9. Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F8–E17.
10. Reilly SD, Faye-Petersen OM. Chorioamnionitis and Funisitis Their Implications for the Neonate. Neoreviews. 2008; 9:e411–e417.
11. Jessop F, Sebire N. Histologic chorioamnionitis: current concepts of diagnosis classification and clinical significance. Fetal Matern Med Rev. 2011; 22:25–44.
12. Park CW, Moon KC, Park JS, Jun JK, Romero R, Yoon BH. The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications. Placenta. 2009; 30:56–61.
13. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol. 1989; 73:383–389.
14. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978; 187:1–7.
15. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996; 97:210–215.
16. Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed. 2009; 94:F13–F16.
17. Choi CW, Kim BI, Koh YY, Choi JH, Choi JY. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants. Pediatr Int. 2005; 47:72–79.
18. Kallapur SG, Kramer BW, Jobe AH. Ureaplasma and BPD. Semin Perinatol. 2013; 37:94–101.
19. Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr. 2010; 156:10–15.e1.
20. Plakkal N, Soraisham AS, Trevenen C, Freiheit EA, Sauve R. Histological chorioamnionitis and bronchopulmonary dysplasia: a retrospective cohort study. J Perinatol. 2013; 33:441–445.
21. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Developmental Epidemiology Network Investigators. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002; 140:171–176.
22. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics. 2009; 123:1314–1319.
23. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics. 1994; 93:712–718.
24. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-lβ, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997; 177:825–830.
25. Ghezzi F, Gomez R, Romero R, Yoon BH, Edwin SS, David C, Janisse J, Mazor M. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol. 1998; 78:5–10.
26. Choi CW, Kim BI, Joung KE, Lee JA, Lee YK, Kim EK, Kim HS, Park JD, Choi JH. Decreased expression of transforming growth factor-beta1 in bronchoalveolar lavage cells of preterm infants with maternal chorioamnionitis. J Korean Med Sci. 2008; 23:609–615.
27. Dammann O, Brinkhaus MJ, Bartels DB, Dördelmann M, Dressler F, Kerk J, Dörk T, Dammann CE. Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev. 2009; 85:325–329.
28. Woo SJ, Park KH, Jung HJ, Kim S, Choe G, Ahn J, Park KH. Effects of maternal and placental inflammation on retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2012; 250:915–923.
29. Mitra S, Aune D, Speer CP, Saugstad OD. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology. 2014; 105:189–199.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr